Type 2 diabetes: genetic data sharing to advance complex disease research
暂无分享,去创建一个
[1] Stephen C. J. Parker,et al. The genetic architecture of type 2 diabetes , 2016, Nature.
[2] T. Byers. Excess Mortality among Persons with Type 2 Diabetes. , 2016, The New England journal of medicine.
[3] Kyle J. Gaulton,et al. Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors , 2015, PLoS genetics.
[4] Ricardo Villamarín-Salomón,et al. ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..
[5] B. Shields,et al. A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults , 2015, Diabetes Care.
[6] Peter N. Robinson,et al. Human genotype–phenotype databases: aims, challenges and opportunities , 2015, Nature Reviews Genetics.
[7] M. McCarthy,et al. Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans , 2015, Diabetes.
[8] Gil Alterovitz,et al. All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and Health. , 2015, Cancer discovery.
[9] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[10] Benjamin S. Glicksberg,et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.
[11] Tanya M. Teslovich,et al. Genetic fine-mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci , 2015, Nature Genetics.
[12] E. Birney,et al. Using human genetics to make new medicines , 2015, Nature reviews genetics.
[13] Manolis Kellis,et al. FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. , 2015, The New England journal of medicine.
[14] Benjamin J. Keller,et al. Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND) , 2015, PLoS genetics.
[15] Kyoung-Jae Won,et al. Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo , 2015, Cell.
[16] Tom R. Gaunt,et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. , 2015, The lancet. Diabetes & endocrinology.
[17] Christian Gieger,et al. Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation , 2015, PLoS genetics.
[18] B. Nordestgaard,et al. HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study , 2015, Diabetes.
[19] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[20] D. van der A,et al. A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes , 2015, Diabetes.
[21] D. Altshuler,et al. IGF2BP2/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins. , 2015, Cell metabolism.
[22] Kyle J. Gaulton,et al. The Power of Gene-Based Rare Variant Methods to Detect Disease-Associated Variation and Test Hypotheses About Complex Disease , 2015, PLoS genetics.
[23] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[24] Inês Barroso,et al. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility , 2015, Nature communications.
[25] Debbie A Lawlor,et al. Association Analysis of 29,956 Individuals Confirms That a Low-Frequency Variant at CCND2 Halves the Risk of Type 2 Diabetes by Enhancing Insulin Secretion , 2015, Diabetes.
[26] D. Altshuler,et al. High-throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic Beta-cell function. , 2015, Cell metabolism.
[27] Fei Gao,et al. An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins , 2014, Nature Communications.
[28] Tom R. Gaunt,et al. Sixty-Five Common Genetic Variants and Prediction of Type 2 Diabetes , 2014, Diabetes.
[29] Brian T. Lee,et al. The UCSC Genome Browser database: 2015 update , 2014, Nucleic Acids Res..
[30] M. McCarthy,et al. Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity , 2014, Diabetes.
[31] M. Weedon,et al. Targeted Allelic Expression Profiling in Human Islets Identifies cis-Regulatory Effects for Multiple Variants Identified by Type 2 Diabetes Genome-Wide Association Studies , 2014, Diabetes.
[32] Han Xu,et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.
[33] B. Alizadeh,et al. Bilirubin as a Potential Causal Factor in Type 2 Diabetes Risk: A Mendelian Randomization Study , 2014, Diabetes.
[34] L. Groop,et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism , 2014, Proceedings of the National Academy of Sciences.
[35] Kyle J. Gaulton,et al. Identification of a Regulatory Variant That Binds FOXA1 and FOXA2 at the CDC123/CAMK1D Type 2 Diabetes GWAS Locus , 2014, PLoS genetics.
[36] Pierre Fontanillas,et al. Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes , 2014, Proceedings of the National Academy of Sciences.
[37] G. Rutter,et al. ADCY5 Couples Glucose to Insulin Secretion in Human Islets , 2014, Diabetes.
[38] Thomas J. Wang,et al. Metabolite Traits and Genetic Risk Provide Complementary Information for the Prediction of Future Type 2 Diabetes , 2014, Diabetes Care.
[39] M. Woo,et al. PTEN Deletion in Pancreatic α-Cells Protects Against High-Fat Diet–Induced Hyperglucagonemia and Insulin Resistance , 2014, Diabetes.
[40] Nicholette D. Palmer,et al. Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes , 2014, PLoS genetics.
[41] J. Al-Aama,et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes , 2014, Nature.
[42] Amy L. Williams,et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. , 2014, JAMA.
[43] Inês Barroso,et al. Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity , 2014, Diabetes.
[44] M. Fornage,et al. Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection , 2014, Diabetes.
[45] C. Ling,et al. Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes , 2014, Diabetes.
[46] Mark I. McCarthy,et al. A Central Role for GRB10 in Regulation of Islet Function in Man , 2014, PLoS genetics.
[47] S. Kahn,et al. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future , 2014, The Lancet.
[48] Jørgen K. Kanters,et al. KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia , 2014, Diabetes.
[49] N. Cox,et al. Obesity-associated variants within FTO form long-range functional connections with IRX3 , 2014, Nature.
[50] Thomas Meitinger,et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes , 2014, Nature Genetics.
[51] C. Ling,et al. Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion , 2014, PLoS genetics.
[52] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[53] Tanya M. Teslovich,et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility , 2014, Nature Genetics.
[54] Christian Fuchsberger,et al. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. , 2014, American journal of human genetics.
[55] S. Reardon. Pharma firms join NIH on drug development , 2014, Nature.
[56] Kari Stefansson,et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes , 2014, Nature Genetics.
[57] M. Daly,et al. Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.
[58] C. Gieger,et al. Leveraging Cross-Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms , 2014, Cell.
[59] Mark I. McCarthy,et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants , 2013, Nature Genetics.
[60] Tanya M. Teslovich,et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico , 2013, Nature.
[61] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[62] K. Kristiansen,et al. Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. , 2013, American journal of human genetics.
[63] Jason Flannick,et al. Evaluating empirical bounds on complex disease genetic architecture , 2013, Nature Genetics.
[64] Stephen C. J. Parker,et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants , 2013, Proceedings of the National Academy of Sciences.
[65] Stefan Johansson,et al. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes , 2013, Nature Genetics.
[66] Mark I. McCarthy,et al. Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes , 2013, Diabetes.
[67] L. Groop,et al. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes , 2013, Molecular and Cellular Endocrinology.
[68] D. Altshuler,et al. Validating therapeutic targets through human genetics , 2013, Nature Reviews Drug Discovery.
[69] E. Riboli,et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications , 2013, Nature Genetics.
[70] Sara M. Willems,et al. The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis , 2013, BDJ.
[71] Halit Ongen,et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome , 2013, Genome research.
[72] K. Mohlke,et al. Allele-Specific Transcriptional Activity at Type 2 Diabetes–Associated Single Nucleotide Polymorphisms in Regions of Pancreatic Islet Open Chromatin at the JAZF1 Locus , 2013, Diabetes.
[73] M. McCarthy,et al. Insights Into the Molecular Mechanism for Type 2 Diabetes Susceptibility at the KCNQ1 Locus From Temporal Changes in Imprinting Status in Human Islets , 2013, Diabetes.
[74] Kyle J. Gaulton,et al. The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis , 2013, PloS one.
[75] Christian Fuchsberger,et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion , 2012, Nature Genetics.
[76] B. Stranger,et al. Chromatin marks identify critical cell types for fine mapping complex trait variants , 2012, Nature Genetics.
[77] D. Torrents,et al. Identification of Novel Type 2 Diabetes Candidate Genes Involved in the Crosstalk between the Mitochondrial and the Insulin Signaling Systems , 2012, PLoS genetics.
[78] M. McCarthy,et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes , 2012, Diabetologia.
[79] Jake K. Byrnes,et al. Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.
[80] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[81] M. McCarthy,et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. , 2012, Cell metabolism.
[82] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[83] J. Levy,et al. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. , 2012, The New England journal of medicine.
[84] E. Gamazon,et al. Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture? , 2012, American journal of human genetics.
[85] Shane J. Neph,et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.
[86] Tanya M. Teslovich,et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.
[87] Tanya M. Teslovich,et al. The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits , 2012, PLoS genetics.
[88] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[89] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[90] M. McCarthy,et al. Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes , 2012, Diabetes.
[91] Claude Bouchard,et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.
[92] T. Lehtimäki,et al. Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women , 2012, Diabetes Care.
[93] M. Marazita,et al. Genome-wide Association Studies , 2012, Journal of dental research.
[94] Laura J. Scott,et al. Stratifying Type 2 Diabetes Cases by BMI Identifies Genetic Risk Variants in LAMA1 and Enrichment for Risk Variants in Lean Compared to Obese Cases , 2012, PLoS genetics.
[95] Peter Kraft,et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis , 2012, Nature Genetics.
[96] M. Goldman,et al. The Innovative Medicines Initiative: A European Response to the Innovation Challenge , 2012, Clinical pharmacology and therapeutics.
[97] Matthieu Defrance,et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients , 2012, The EMBO journal.
[98] Inês Barroso,et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes , 2012, Nature Genetics.
[99] Wei Lu,et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians , 2011, Nature Genetics.
[100] A. Gloyn,et al. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. , 2011, Molecular genetics and metabolism.
[101] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[102] Tien Yin Wong,et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci , 2011, Nature Genetics.
[103] Hideki Matsui,et al. Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. , 2011, The Journal of clinical investigation.
[104] Ayellet V. Segrè,et al. The Lin28/let-7 Axis Regulates Glucose Metabolism , 2011, Cell.
[105] L. Groop,et al. Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study , 2011, Diabetologia.
[106] Eric Banks,et al. Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction , 2011, Nature Genetics.
[107] Mark I. McCarthy,et al. Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes , 2011, Nature Genetics.
[108] Tom R. Gaunt,et al. Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance , 2011, Diabetes.
[109] E. Zeggini,et al. Synthetic Associations Are Unlikely to Account for Many Common Disease Genome-Wide Association Signals , 2011, PLoS biology.
[110] David B. Goldstein,et al. The Importance of Synthetic Associations Will Only Be Resolved Empirically , 2011, PLoS biology.
[111] Naomi R. Wray,et al. Synthetic Associations Created by Rare Variants Do Not Explain Most GWAS Results , 2011, PLoS biology.
[112] M. McCarthy. Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.
[113] C. Freeman,et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes , 2010, Nature Genetics.
[114] Stephen C. J. Parker,et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. , 2010, Cell metabolism.
[115] Yusuke Nakamura,et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B , 2010, Nature Genetics.
[116] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[117] D. Altshuler,et al. Consistent Association of Type 2 Diabetes Risk Variants Found in Europeans in Diverse Racial and Ethnic Groups , 2010, PLoS genetics.
[118] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[119] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[120] M. King,et al. Genetic Heterogeneity in Human Disease , 2010, Cell.
[121] T. Assimes,et al. Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans , 2010, Diabetes.
[122] Alex Doney,et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.
[123] Kyle J. Gaulton,et al. A map of open chromatin in human pancreatic islets , 2010, Nature Genetics.
[124] Christian Gieger,et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.
[125] David B. Goldstein,et al. Rare Variants Create Synthetic Genome-Wide Associations , 2010, PLoS biology.
[126] G. Rutter. Think zinc: New roles for zinc in the control of insulin secretion , 2010, Islets.
[127] K. Dewar,et al. Rfx6 Directs Islet Formation and Insulin Production in Mice and Humans , 2009, Nature.
[128] Boris Lenhard,et al. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3 , 2009, Proceedings of the National Academy of Sciences.
[129] J. Hirschhorn. Genomewide association studies--illuminating biologic pathways. , 2009, The New England journal of medicine.
[130] D. Goldstein. Common genetic variation and human traits. , 2009, The New England journal of medicine.
[131] K. Hemminki,et al. Familial Risks for Type 2 Diabetes in Sweden , 2009, Diabetes Care.
[132] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[133] Nicola L. Beer,et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver , 2009, Human molecular genetics.
[134] M. Loder,et al. Insulin Storage and Glucose Homeostasis in Mice Null for the Granule Zinc Transporter ZnT8 and Studies of the Type 2 Diabetes–Associated Variants , 2009, Diabetes.
[135] Ralph Kimball,et al. The Data Warehouse Lifecycle Toolkit , 2009 .
[136] Ralph Kimball,et al. Kimball's Data Warehouse Toolkit Classics: The Data Warehouse Toolkit, 2nd Edition; The Data Warehouse Lifecycle, 2nd Edition; The Data Warehouse ETL Toolk , 2009 .
[137] M. Daly,et al. Genetic Mapping in Human Disease , 2008, Science.
[138] Manuel A. R. Ferreira,et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.
[139] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[140] F. Harrell. Faculty Opinions recommendation of Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. , 2008 .
[141] M. Fowler. Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.
[142] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[143] J. Gulcher,et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.
[144] M. McCarthy,et al. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.
[145] Marcia M. Nizzari,et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.
[146] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[147] Weihua Guan,et al. Meta-Analysis of 23 Type 2 Diabetes Linkage Studies from the International Type 2 Diabetes Linkage Analysis Consortium , 2007, Human Heredity.
[148] T. Wadden,et al. Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD) , 2006, Clinical trials.
[149] David M Nathan,et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. , 2006, The New England journal of medicine.
[150] H. Stefánsson,et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.
[151] P. Stenson,et al. Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.
[152] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[153] M. McCarthy,et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.
[154] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[155] J. Pritchard. Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.
[156] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[157] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[158] J. Danesh,et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes , 2017 .
[159] M. Anubha. Large-scale exome chip association analysis identifies novel type 2 diabetes susceptibility loci and highlights candidate effector genes , 2016 .
[160] Tanya M. Teslovich,et al. Association analyses of 249 , 796 individuals reveal 18 new loci associated with body mass index , 2012 .
[161] N. Rahman,et al. A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2010 .
[162] J. Deelen,et al. A Mendelian randomization study , 2022 .
[163] in Risk: A Mendelian Randomization Study” , 2022 .